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Identification of specific and universal virulence factors in
Burkholderia cenocepacia strains by using multiple infection
hosts
Abstract
Over the past few decades, strains of the Burkholderia cepacia complex have emerged as important
pathogens for patients suffering from cystic fibrosis. Identification of virulence factors and assessment
of the pathogenic potential of Burkholderia strains have increased the need for appropriate infection
models. In previous studies, different infection hosts, including mammals, nematodes, insects, and
plants, have been used. At present, however, the extent to which the virulence factors required to infect
different hosts overlap is not known. The aim of this study was to analyze the roles of various virulence
factors of two closely related Burkholderia cenocepacia strains, H111 and the epidemic strain K56-2, in
a multihost pathogenesis system using four different model organisms, namely, Caenorhabditis elegans,
Galleria mellonella, the alfalfa plant, and mice or rats. We demonstrate that most of the identified
virulence factors are specific for one of the infection models, and only three factors were found to be
essential for full pathogenicity in several hosts: mutants defective in (i) quorum sensing, (ii) siderophore
production, and (iii) lipopolysaccharide biosynthesis were attenuated in at least three of the infection
models and thus may represent promising targets for the development of novel anti-infectives.
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 2 
Abstract. 23 
Over the past few decades, strains of the Burkholderia cepacia complex (Bcc) have 24 
emerged as important pathogens for patients suffering from cystic fibrosis (CF). 25 
Identification of virulence factors and assessment of the pathogenic potential of 26 
Burkholderia strains have increased the need for appropriate infection models. In 27 
previous studies different infection hosts, including mammals, nematodes, insects and 28 
plants, have been used. At present, however, it is not known to which extent the virulence 29 
factors required to infect different hosts overlap. The aim of this study was to analyze the 30 
role of various virulence factors of two closely related B. cenocepacia strains, H111 and 31 
the epidemic strain K56-2, in a multihost pathogenesis system using four different model 32 
organisms: Caenorhabditis elegans, Galleria mellonella, the plant alfalfa and mice or 33 
rats. We demonstrate that most of the identified virulence factors are specific for one of 34 
the infection models and only three factors were found to be essential for full 35 
pathogenicity in several hosts: i) mutants defective in quorum sensing, ii) siderophore 36 
production and iii) lipopolysaccharide (LPS) biosynthesis were attenuated in at least three 37 
of the infection models and thus may represent promising targets for the development of 38 
novel antiinfectives. 39 
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 3 
Introduction. 40 
The Burkholderia cepacia complex (Bcc) comprises a group of currently 17 formally 41 
named bacterial species: Burkholderia cepacia, Burkholderia multivorans, Burkholderia 42 
cenocepacia, Burkholderia stabilis, Burkholderia vietnamiensis, Burkholderia dolosa, 43 
Burkholderia ambifaria, Burkholderia anthina, and Burkholderia pyrrocinia (46, 69), in 44 
addition to Burkholderia ubonensis, Burkholderia latens, Burkholderia diffusa, 45 
Burkholderia arboris, Burkholderia seminalis, and Burkholderia metallica (71), 46 
Burkholderia lata and Burkholderia contaminans (70). Strains of the Bcc are 47 
ubiquitously distributed in nature and have been isolated from soil, water, the rhizosphere 48 
of plants, industrial settings, hospital environments, and from infected humans. Some Bcc 49 
strains have enormous biotechnological potential and have been used for bioremediation 50 
of recalcitrant xenobiotics, plant growth promotion, and biocontrol purposes. At the same 51 
time, however, Bcc strains have emerged as problematic opportunistic pathogens in 52 
patients with cystic fibrosis and immunocompromised individuals (12, 19, 44, 46). The 53 
clinical outcome of Bcc infections ranges from asymptomatic carriage to a fulminant and 54 
fatal pneumonia, the so-called ‘cepacia syndrome’ (30). Apart from acquisition from the 55 
environment, patient-to-patient transmission and indirect nosocomial acquisition from 56 
contaminated surfaces have caused several outbreaks within and between regional CF 57 
centers (55). Although all Bcc species have been isolated from both environmental and 58 
clinical sources, B. cenocepacia and B. multivorans are most commonly found in clinical 59 
samples (12, 44). 60 
Members of the Bcc are not only opportunistic pathogens of humans but can also cause 61 
infections in a diverse range of species including animals, nematodes and plants (59). 62 
 at Universitaet Zuerich on Decem
ber 3, 2009 
iai.asm
.org
D
ow
nloaded from
 
 4 
This allowed developing various infection models using mouse or rat , the nematode 63 
Caenorhabditis elegans, onions or the plant alfalfa as infection hosts. More recently, 64 
larvae of the wax moth Galleria mellonella have been used as infection hosts of Bcc 65 
strains (58). These models have been employed to investigate the virulence of different 66 
Bcc species as well as of mutants to understand the importance of specific genes in 67 
disease. These infection models have also been applied to studies of host response, gene 68 
therapy, antimicrobial delivery, and immunization for prevention of Bcc lung disease (6, 69 
32, 51). 70 
Previous work has identified several virulence factors that may play a role in infections 71 
caused by Bcc strains. Some isolates have been demonstrated to be capable of surviving 72 
within eukaryotic cells such as respiratory epithelial cells, macrophages and amoebae (7, 50, 73 
56). Other virulence factors that have been identified by the use of different infection models 74 
include the quorum-sensing system (40), biofilm formation (14), iron-chelating 75 
siderophores (16), proteases (15), type III and IV secretion system (20, 24, 67), melanin 76 
production (77), catalase (38), LPS (41), cable pili and flagella (57, 68), surface 77 
exopolysaccharides (11), a lysR regulator (4), capsule (29) and intrinsic antimicrobial 78 
resistance (10). Recently, a phenylacetic acid (PA) catabolic pathway was shown to be 79 
required for full pathogenicity of B. cenocepacia in the C. elegans infection model (37). 80 
At present, knowledge on the importance of these factors in different infection hosts is 81 
scarce. This study was initiated to identify both host specific and conserved mechanisms of 82 
pathogenicity in C. elegans, G. mellonella, alfalfa and murine infection models. We 83 
demonstrate that some virulence factors were important for pathogenicity in more than 84 
one infection model while other factors were found to be host specific. N-acyl 85 
 at Universitaet Zuerich on Decem
ber 3, 2009 
iai.asm
.org
D
ow
nloaded from
 
 5 
homoserine lactone (AHL)-dependent quorum sensing was identified as a highly 86 
conserved regulatory mechanism for expression of pathogenic traits. Siderophore 87 
production and an intact LPS were important for virulence in all animal models. 88 
However, we also identified several virulence factors that were only required for 89 
pathogenesis in one of the models. 90 
 91 
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 6 
Materials and Methods 92 
 93 
Bacterial strains and growth conditions.  94 
The bacterial strains and plasmids used in the present study are described in Table S1 in 95 
the supplemental material. All strains were grown aerobically in modified Luria-Bertani 96 
(LB) broth (1) (containing 4 g of NaCl/liter instead of 10 g of NaCl/liter) at 37°C. Solid 97 
media contained 15 g of agar/liter (Conda, Madrid, Spain). Growth was determined 98 
spectrophotometrically by measurement of  the optical density at 600 nm. 99 
 100 
G. mellonella killing assays. Infection of G. mellonella larvae was performed as 101 
described previously (31, 58) with some modifications. Caterpillars in the final larval 102 
stage (Brumann, Zürich or Hebeisen, Zürich) were stored in wooden shavings at 15°C 103 
and used within 2-3 weeks. Bacterial overnight cultures grown in LB broth were diluted 104 
1:100 in 30 ml and cultivated to an optical density (OD600) of 0.4 to 0.7. Cultures were 105 
centrifuged, and pellets were resuspended in 10 mM MgSO4 (E. Merck, Dietikon, 106 
Switzerland) and the OD600 was adjusted to 0.125, corresponding to approximately 4x107 107 
CFU/ml. Bacterial suspensions were supplemented with 100 µg/ml ampicillin to prevent 108 
contamination, as the Burkholderia strains used are intrinsically resistant to ampicillin. 109 
Cultures of strains containing plasmid pMLBADaiiA or pBAH27 were supplemented 110 
with 100 µg/ml trimethoprim or 15 µg/ml gentamicin, respectively. As a control E. coli 111 
OP50 cells were injected without additives. A 1 ml syringe (BD Plastipak, Madrid, 112 
Spain) with a 27G x 7/8” needle (Rose GmbH, Trier, Germany) was used to inject a 10 µl 113 
aliquot into G. mellonella via the hindmost proleg. The injection area was previously 114 
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 7 
disinfected with a cotton swab soaked in ethanol. Ten to fourteen healthy, randomly 115 
chosen larvae were injected per strain and incubated in Petri dishes at 30°C in the dark. 116 
To monitor killing of animals due to physical injury or infection by contaminating 117 
pathogens larvae were injected with 10 µl MgSO4 containing appropriate antibiotics. The 118 
number of dead larvae was scored 20, 24, 40, 48 and 72 hours after infection. Dead larvae 119 
turned black as a result of melanization and did not response to touch. Experiments with 120 
more than one dead larva in the MgSO4-control group were not considered and repeated. 121 
Data are mean values of at least three independent experiments.  122 
 123 
Nematode killing assays. Nematode killing assays were performed essentially as 124 
described by Köthe et al. (35). Briefly, overnight cultures were adjusted to a density of 125 
about 1.3 x 104 to 1.5 x 104 CFU/ml, and 100 µl of the suspensions was plated on six-126 
well plates containing nematode growth medium (NGM II) for slow killing assays. After 127 
24 h of incubation at 37 °C a bacterial lawn was formed and approximately 20 to 40 128 
hypochlorite-synchronized L4 larvae of C. elegans Bristol N2 (obtained from the 129 
Caenorhabditis Genetics Centre, University of Minnesota, Minneapolis, USA) were used 130 
to inoculate the plates. The actual number of worms was determined by using a Stemi 131 
SV6 microscope (Zeiss, Oberkochen, Germany) at a magnification of x 50. Plates were 132 
then incubated at 20 °C and scored for live worms considering nematodes dead when 133 
they failed to respond to touch. The percentage of live worms and their morphological 134 
appearance was registered after two days. After five days, the total number of nematodes 135 
including parental and progeny nematodes (if existing) was scored. All experiments were 136 
carried out at least three times, and E. coli OP50 was used as a negative control in the 137 
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 8 
assays. Pathogenicity of strains was scored according to the following criteria: i) sick 138 
appearance at day 2 including reduced locomotive capacity and the presence of a 139 
distended intestine, ii) percentage of live worms after two days ≤50%, and iii) total 140 
number of worms after five days ≤100. For differentiating mild from severe infections, 141 
the presence of any one, two or three of these criteria was scored as 1, 2 and 3 (as 142 
described by 7 and 71). While a strain was considered pathogenic when at least one 143 
criterion was observed, a strain was described as non pathogenic when no symptoms of 144 
disease were observed during the course of the infection experiment (pathogenicity score 145 
0). 146 
 147 
Alfalfa virulence assays. Alfalfa seeds (variety 57Q77) were provided by Pioneer Hi-148 
Bred International, Inc. (Johnston, Iowa). Alfalfa seeds were prepared as previously 149 
described (5). To disinfect and accelerate germination, they were immersed in 150 
concentrated sulfuric acid (approximately 20 ml for 300 seeds) for 20 min and then 151 
washed with 500 ml of distilled water (dH2O) four times. The seeds were covered with 60 152 
ml of sterile dH2O in a 125-ml Erlenmeyer flask and incubated at 32°C with shaking for 6 153 
to 8 hours to encourage uniform imbibition and germination. The seeds were rinsed twice 154 
with 60 ml of sterile dH2O and incubated overnight in 60 ml of sterile dH2O at 32°C with 155 
shaking. The following day, the seedlings were placed in 24-well plates (Becton 156 
Dickinson) containing 2 ml of water agar (4). A total of 30 µl (normalized to an OD600 = 157 
0.3) overnight cultures grown in 5 ml LB at 37°C with shaking was used to surface 158 
inoculate three unwounded seedlings per well. The 24-well plates containing seedlings 159 
were sealed with parafilm and incubated in a warm room (37°C) under a desk lamp 160 
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 9 
producing artificial light. Controls included seedlings inoculated with 10 µl of 0.85% 161 
NaCl and untreated seedlings. The seedlings were visually monitored for disease 162 
symptoms including yellow leaves, stunted roots, and brown necrotic regions at 5 days 163 
postinfection (p.i.). Each strain was tested with 10-12 seedlings per experiment. Data 164 
represent the mean ± standard deviation values of three assays. 165 
 166 
Animal studies. Chronic infection experiments were performed using the rat agar bead 167 
infection model originally described by Cash et al. (9), and modified for B. cenocepacia 168 
as previously described (61). Groups of 10 rats were infected intratracheally with H111 169 
or K56-2 encased in agar beads. On day 7 post infection, lungs were removed from 3-5 170 
animals per group, homogenized, serially diluted and plated on trypticase soy agar to 171 
determine the number of bacteria persisting in the lung. The lungs from 4-5 additional 172 
animals per group were fixed in 10% formalin and examined for quantitative and 173 
qualitative histopathological changes.  174 
 175 
Detection of AidA. For Western blotting whole-cell proteins were separated on a 15% 176 
SDS-PAGE gel and transferred to a polyvinylidene difluoride (PVDF) membrane 177 
(Immobilon-P, Millipore, Eschborn, Germany). The membrane was probed with the anti-178 
AidA antibodies (27), and detection reactions were performed with alkaline phosphatase-179 
conjugated anti-rabbit immunoglobulin G (Sigma, Steinheim, Germany) according to the 180 
recommendations of the manufacturer (Roche, Mannheim, Germany).  181 
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 10 
Results and Discussion 182 
 183 
Bcc strains exhibit differential virulence in different infection models. Previous work 184 
has demonstrated that the nematode C. elegans is a valuable host for studying virulence 185 
of Burkholderia species (8). However, it is not known whether factors identified in the 186 
nematode model contribute to virulence in other infection hosts. As an initial step to 187 
address this issue we investigated the virulence of different Bcc strains in two non-188 
mammalian infection hosts, namely C. elegans and G. mellonella (Table 1). While in 189 
most cases the virulence levels were similar in both infection models, some strains were 190 
pathogenic for one but not the other host. For example B. anthina LMG20983 effectively 191 
killed C. elegans but was virtually avirulent in the G. mellonella model. The opposite is 192 
true for B. vietnamiensis LMG10929. Differential virulence, albeit with less dramatic 193 
effects, was also observed with B. stabilis R6281, B. multivorans LMG18822, and B. 194 
cepacia R18194.  195 
Interestingly, even three closely related B. cenocepacia strains, H111, K56-2 and J2315, 196 
showed marked differences in their pathogenic potential in the two infection models. 197 
J2315 was less virulent than K56-2 in G. mellonella and C. elegans (data not shown), in 198 
spite of the fact that both strains belong to the epidemic ET-12 lineage. Strains of this 199 
lineage are transmissible and have resulted in high mortality in CF patients (47, 64). This 200 
is in contrast to the CF isolate H111, which did not cause any symptoms in the patient 201 
and could not be detected in sputum samples 5 years after it had been isolated (22). Strain 202 
K56-2 killed G. mellonella with a higher rate than H111; however the opposite effect was 203 
observed in C. elegans (Fig. 1).  204 
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 11 
The rat agar bead model for studying chronic respiratory infections has been used 205 
extensively to study virulence properties of B. cenocepacia strains K56-2 (29, 62) and 206 
J2315 (5). As the pathogenicity of K56-2 and H111 varied in the C. elegans and G. 207 
mellonella models, we assessed the virulence of this strain in the agar bead model. There 208 
was no difference in the ability of H111 versus that of K56-2 to cause a persistent 209 
infection in the rat as the recovery rates from infected lungs were log 4.9 ± 0.45 CFU per 210 
ml of lung homogenate and 4.65 ± 0.41 CFU at 7 days post infection, respectively. There 211 
was a marked qualitative difference between the strains, however, in the lung 212 
histopathology observed in infected animals. K56-2 infected lungs had extensive 213 
inflammatory infiltrates with predominantly polymorphonuclear cells, whereas H111 214 
infected lungs showed only slight signs of inflammation (Fig. 2). Infections with a 10-215 
fold higher inoculum of H111, resulting in log 6.4 ± 0.14 CFU recovered per ml of lung 216 
homogenate at day 7 post infection, did result in increased lung histopathology. Although 217 
the pathology was similar to that observed with K56-2, the inflammation remained 218 
restricted to the airways (data not shown). Taken together, these results suggest that the 219 
virulence of Bcc strains in a particular infection model is strain-dependent, likely due to 220 
the expression of specific virulence factors.  221 
 222 
The role of QS in virulence in different infection models. Most Burkholderia species 223 
produce N-octanoylhomoserine lactone (C8-HSL), which is synthesized by the AHL 224 
synthase CepI. As the cell density increases, C8-HSL accumulates in the growth medium 225 
until a critical threshold concentration is attained. At this point C8-HSL binds to its 226 
cognate LuxR-type receptor protein CepR, which, in turn, leads to the induction or 227 
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 12 
repression of target genes (18, 62). Previous work has shown that CepIR homologues 228 
contribute to virulence in Burkholderia species in the nematode C. elegans (35) and 229 
murine species (63).  230 
 231 
Using a quorum quenching approach, i.e. the heterologous expression of the Bacillus sp. 232 
strain 240B1 AHL lactonase AiiA, Wopperer et al. (75) demonstrated that nematode 233 
pathogenicity is AHL-dependent in all investigated Bcc strains. Intriguingly, expression 234 
of AiiA in three of the investigated strains not only abolished virulence in C. elegans but 235 
also in G. mellonella (Table 1). These results suggest that expression of factors required 236 
for killing of the wax moth larvae are AHL-regulated and strengthen the view that QS in 237 
Bcc strains is a major checkpoint for the control of pathogenicity. 238 
 239 
To investigate the role of QS in pathogenesis of B. cenocepacia in better detail, the 240 
virulence of wild type and QS-deficient mutants of two B. cenocepacia strains, H111 and 241 
K56-2, was compared in C. elegans, G. mellonella, alfalfa and a mouse or rat respiratory 242 
infection model (Table 2). In this context it is important to note that the ET-12 strain 243 
K56-2 contains a second QS system designated cciIR, which is present on the 244 
cenocepacia island (cci) and utilizes C6-HSL as the major signal molecule (3, 48). 245 
Previous work has demonstrated that cciI and cepI mutants are attenuated in a rat model 246 
of chronic lung infection (3). When G. mellonella was infected with 4x105 CFUs of strain 247 
H111 or K56-2 the larvae died and turned black as a result of melanization within 48 248 
hours (Fig. 3). Inactivation of cepI in H111 reduced the virulence of this strain to the 249 
level of the control, indicating that QS plays an important role in wax moth pathogenesis. 250 
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 13 
Surprisingly, however, we observed that the cepR mutant, H111-R, was as pathogenic as 251 
the wild type in G. mellonella (Table 2). This discrepancy may be explained by fact that 252 
CepR acts both as a positive and negative regulator in B. cenocepacia (53). It is therefore 253 
likely that in the cepR mutant expression of G. mellonella-specific virulence factors is de-254 
repressed. In contrast to H111, neither the cepI nor the cciI or the cepI cciI double mutant 255 
of K56-2 was attenuated in G. mellonella, indicating that expression of virulence factors 256 
required for wax moth killing are AHL-independent in K56-2.  257 
Previous work has shown that both a cepI and a cepR mutant of H111 exhibit attenuated 258 
virulence in C. elegans (35). In agreement with these results we observed that the cepI 259 
and the cepI cciI double mutants of K56-2, K56-I2 and K56-2cepIcciI, respectively, 260 
showed reduced killing of C. elegans (Table 2). However, the cciI mutant, K56-2cciI, 261 
was found to be as virulent as the wild type strain. As one of the major virulence factors 262 
for C. elegans pathogenicity is AidA (27), we determined the expression levels of this 263 
protein in the wild type and QS mutant strains. Western blot analysis using AidA-specific 264 
antibodies showed that expression of AidA is dependent on CepI but not CciI (Fig. 4). 265 
Addition of AHLs to the growth medium of the cepI and cepI cciI mutants restored not 266 
only expression of AidA but also virulence against C. elegans to the level of the wild type 267 
(data not shown). These results clearly demonstrate that AHL-dependent expression of 268 
AidA plays a central role for nematode pathogenicity of B. cenocepacia. 269 
While infection of alfalfa with the cepI or the cepR mutant of H111 showed less severe 270 
disease symptoms relative to the wild type, QS mutations had no effect on virulence of 271 
K56-2. These results may suggest that either the QS circuitry controls only partially 272 
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 14 
overlapping sets of genes or that K56-2 has additional virulence factors that are AHL-273 
independently expressed. 274 
 275 
The contribution of selected QS-regulated virulence factors to pathogenesis in 276 
different infection hosts.To date, knowledge on the role of QS-regulated virulence 277 
factors in different infection models is scarce. To address this issue in better detail we 278 
tested mutant strains with defects in QS-regulated genes for virulence in different hosts. 279 
 280 
In agreement with previous work (27) the we found that the aidA mutant H111-A is 281 
greatly attenuated in C. elegans (Table 3). However, the mutant was as virulent as the 282 
wild type strain in the wax moth, the alfalfa and the at lung infection model (Table 3; Fig. 283 
2). These results indicate that AidA is not a general virulence factor but is highly specific 284 
for  C. elegans pathogenicity. 285 
The siderophore ornibactin whose production is negatively QS-regulated has been 286 
demonstrated to be an important virulence factor in chronic respiratory infections (60, 61, 287 
73). We tested two ornibactin-deficient mutants for virulence in the C. elegans, wax moth 288 
and alfalfa infection models: K56-2orbA, which is deficient in the outer membrane 289 
receptor for ornibactin (73), and K56-2I117, which is deficient in pvdA, a gene required 290 
for the production and uptake of ornibactin (61). Both mutants were found to be 291 
attenuated in virulence against C. elegans and G. mellonella. The pvdA mutant was 292 
slightly attenuated in the alfalfa model, but the orbA mutant was as virulent as the wild 293 
type. It is possible that ornibactin is taken up by other siderophore receptors, although 294 
less efficiently, which might explain the difference in attenuation between the orbA and 295 
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 15 
pvdA mutants. Since the pvdA mutant was only slightly attenutated, these results suggest 296 
that ornibactin-mediated iron uptake is an essential factor for pathogenicity in animals but 297 
not in plants. 298 
The production of extracellular proteolytic activity is stringently QS-regulated in Bcc 299 
strains (23, 34). Two zinc metalloproteases, zmpA and zmpB,  are positively regulated by 300 
CepR and CciR (34, 48, 63). Previous work has shown that inactivation of either zmpA or 301 
zmpB in K56-2 results in reduced histopathological changes in rats relative to the parent 302 
strain (15, 34). However, in C. elegans, G. mellonella or alfalfa no significant differences 303 
between mutants K56-2-9 (zmpA) or K56-2zmpB (zmpB) and the wild type K56-2 could 304 
be observed (Table 3). Another protease, HtrA, which is localized in the periplasmic 305 
compartment and is AHL-independently expressed, was previously shown to be involved 306 
in osmotic and thermal stress resistance and required for persistence in the rat agar bead 307 
model of chronic lung infection (21). As with ZmpA and ZmpB, HtrA had no effect on 308 
pathogenicity of B. cenocepacia in the other infection models used in this study (Table 309 
3). These data suggest that proteases are only important for the infection of mammalian 310 
hosts. One explanation for this finding could be that proteases are particularly important 311 
for modulating the host immune response by degrading specific tissue components such 312 
as collagen and fibronectin and for obstructing immune proteins, including neutrophil 313 
alpha-1 proteinase inhibitor, gamma interferon and immunoglobulins (15, 33, 34). As 314 
neither nematodes, insects, nor plants possess such advanced immune systems the 315 
proteases may have no target and are therefore ineffective in these hosts. 316 
We also tested a gspE mutant of H111, H111gspE, in C. elegans, G. mellonella and 317 
alfalfa. H111gspE is mutated in the general secretory pathway, which is part of a type II 318 
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 16 
secretion pathway responsible for the export of proteases and lipases (35) that has been 319 
shown to be negatively regulated by the CepR system in K56-2 (66). This mutant was not 320 
significantly attenuated in the three infection models (Table 3), suggesting that proteases 321 
and lipases  are not important for virulence in plant and invertebrate  hosts. 322 
 323 
The role of mammalian virulence factors in pathogenesis of non-mammalian hosts. 324 
Previous work has identified several virulence factors that affect virulence in mammalian 325 
hosts: opcI, a gene located on the cci island of ET-12 lineage strains, which encodes an 326 
outer membrane protein that is closely related to the OmpC family of outer membrane 327 
bacterial porins and may act as a pore for the transport of small molecules (3), bscN, 328 
which encodes a component of a type III secretion system (67), and hldA, which is 329 
involved in LPS biosynthesis (41).  330 
The opcI mutant was only attenuated in the chronic respiratory rat agar bead model but 331 
not in any of the other models, suggesting a specific role of this membrane protein for 332 
virulence in mammalian hosts (Table 3). The bscN mutant of K56-2 was found to be 333 
required for full virulence in C. elegans but not G. mellonella or alfalfa. In agreement 334 
with the study of Markey et al. (49) we observed that the virulence of the bscN mutant 335 
was reduced by 40% relative to the wild type, indicating that type III secretion is not only 336 
important for virulence in a murine model of infection (67) but also for nematode 337 
pathogenicity.  338 
The mutant Sal1 is defective in expression of the hldAD operon, encoding two enzymes 339 
involved in the modification of heptose sugars prior to their incorporation into the LPS 340 
core oligosaccharide. The Sal1 mutant, which was previously shown to be defective in 341 
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survival in the rat agar bead model of lung infection (41), was found to be attenuated in 342 
the C. elegans and G. mellonella infection models but was as virulent as the wild type in 343 
the alfalfa model. LPS is known to strongly stimulate the immune signal cascades in 344 
vertebrates and invertebrates via the innate immune system. The receptors, which are 345 
responsible for the recognition of LPS, belong to the familiy of Toll-like proteins (39). In 346 
this light, it may not be surprising that a mutant with an altered LPS structure is 347 
attenuated in pathogenicity. Interestingly, the mutant was not attenuated in alfalfa, in 348 
spite of the fact that plants are also capable of recognizing bacterial LPS and, in response, 349 
can trigger defence mechanisms (17). For example, LPS of an endophytic B. cepacia 350 
strain was demonstrated to induce various defense genes in Arabidopsis thaliana 351 
including a gene encoding a NO synthase. The observed difference in virulence in the 352 
animal and alfalfa models may be explained by the fact that the LPS receptor of the plant, 353 
which has no significant homology with the mammalian LPS receptor, has a much lower 354 
binding affinity for LPS (76).  355 
The two shiny colony variants K56-2 S76 and K56-2 0225 exhibit an altered colony 356 
morphology as a results of a mutation of gene BCAS0225, which encodes a putative 357 
transcriptional regulator belonging to the LysR family (4). Both mutants were avirulent in 358 
an alfalfa seedling infection model and mutant S76 also produced significantly less lung 359 
histopathology than the rough parental strain K56-2. However, both mutants were 360 
indistinguishable from the wild type strain in their virulence in the C. elegans and G. 361 
mellonella infection models (Table 3). This indicates that BCAS0225 controls expression 362 
of a factor(s) required for virulence in alfalfa and rats, but not in C. elegans and G. 363 
mellonella. 364 
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K56-2 RSF12, a mutant with a defect in the response regulator BCAL2831, was shown to 365 
be unable to compete with the parental strain K56-2 in a rat model of chronic lung 366 
infection (21). However, this mutant was not attenuated in any other infection model used 367 
in this study. 368 
 369 
 370 
Conclusions 371 
Evidence that has accumulated over the past few years has demonstrated that there is a 372 
high degree of conservation of virulence mechanisms required to infect different hosts 373 
(36, 42, 74). It is thought that commonalities in bacterial virulence strategies exist 374 
because they were initially evolved to combat their natural predators in the environment. 375 
This idea is also strongly supported by the fact that the innate immune systems of 376 
vertebrates and invertebrates share many common features that have been conserved 377 
during evolution (26). Given the practical advantages in their use, non-mammalian 378 
infection models have been established as attractive alternatives to traditional animal 379 
models (36).  380 
Strains of the Bcc are commonly found in the rhizosphere of plants (52) and it is likely 381 
that these organisms have evolved defence mechanisms that confer on them a survival 382 
advantage in this niche. In fact, Bcc strains were shown to infect various hosts, including 383 
mammals, nematodes, and plants (for a review see (59). Depending on the infection 384 
model, various factors have been implicated in virulence in these models (62). In this 385 
study we investigated to which extent the virulence factors required for pathogenesis in 386 
the different hosts overlap. In agreement with previous studies we show that AHL-387 
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mediated QS plays a central role in the control of pathogenic traits in Bcc strains. Rather 388 
than controlling one universal pathogenicity factor, our data support a model in which QS 389 
regulates expression of a battery of virulence factors, which vary in their importance for 390 
infections in different host organisms. For example, AidA, expression of which is 391 
stringently QS-regulated and which is essential for killing of C. elegans, played no role in 392 
any of the other pathogenesis models and thus appears to be a specific virulence factor 393 
required for infection of nematodes. AHL-dependent production of proteases was found 394 
to be important for pathogenicity of B. cenocepacia in mammals but not in invertebrates 395 
or alfalfa. QS-regulated synthesis of siderophores is important for virulence in mammals, 396 
C. elegans and G. mellonella but not alfalfa. Since expression of virulence factors in 397 
multiple hosts is coordinated by AHL-dependent QS systems, we believe that QS may be 398 
a particularly attractive target for the development of compounds that can be used for 399 
treating Bcc strain infections. 400 
Interestingly, QS mutants of K56-2, although attenuated in a mammalian and the C. 401 
elegans infection model, were as virulent as the wild type in the alfalfa and G. mellonella 402 
model, suggesting that in this strain expression of some virulence factors is AHL-403 
independent. Furthermore, our investigations identified several virulence factors, which 404 
to our knowledge are AHL-independently expressed and are important for pathogenicity 405 
in some of the infection models, but not others. In this context, it is worth noting that the 406 
production of LPS was found to be particularly critical for infection, as a mutant with a 407 
defective LPS structure was attenuated in all animal models.  408 
These studies also demonstrate that several virulence factors are host specific with little 409 
correlation between seemingly related invertebrate models. Bcc strains appear to utilze 410 
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different virulence mechanisms to compete for survival with soil nematodes, plants and 411 
mammalian hosts. This strategy is markedly different from the one employed by the 412 
opportunistic pathogen Pseudomonas aeruginosa, which was demonstrated to utilize 413 
virulence mechanisms that are conserved in diverse infection hosts (1, 36, 42). In fact, in 414 
P. aeruginosa only very few host-specific virulence factor could be identified and the 415 
large overlap between virulence factors required for non-mammalian and mammalian 416 
pathogenesis validated the use of invertebrates as surrogate hosts. We could only identify 417 
a few universal virulence factors in B. cenocepacia and we therefore believe that 418 
extrapolations from non-mammalian infection models to mammalian infections have to 419 
be taken with caution. 420 
 421 
 422 
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Figure legends 688 
 689 
Figure 1. Virulence of B. cenocepacia is strain specific. The killing kinetics of strains 690 
H111 (○) and K56-2 (●) were determined in the C. elegans (A) and G. mellonella (B) 691 
infection models. While strain H111 kills C. elegans faster than K56-2 the opposite is 692 
true for G. mellonella. 693 
 694 
Figure 2. B. cenocepacia strain K56-2 causes more inflammatory response in 695 
infected rat lungs than strain H111. Representative hematoxylin and eosin stained 696 
sections of rat lungs infected with B. cenocepacia K56-2 (A) and H111 (B). Mounted 697 
lung sections were examined by light microscopy for pathological changes using an 698 
Olympus IX70 microscope, and images were taken using a cooled 12-Bit CCD Retiga 699 
EXi camera (QImaging).  Image analysis was performed using Volocity 4.2.0 software 700 
(Improvision Ltd). Magnification: x 40. These sections are typical of groups of 3 animals. 701 
 702 
Figure 3. CepI but not AidA is essential for G. mellonella pathogenicity of B. 703 
cenocepacia H111. Wax moth larvae infected with 4x105 cells of the wild type strain 704 
H111 (A), the cepI mutant H111-I (B), the aidA mutant H111-A (C) and the MgSO4-705 
control (D). Pictures were taken 48 h post infection.  706 
 707 
Figure 4. Expression of AidA in B. cenocepacia K56-2 is CepI- but not CciI-708 
dependent. Western blot analysis of the wild type K56-2, the cepI mutant K56-I2, the 709 
cciI mutant K56-2cciI and cepIcciI double mutant K56-2cepIcciI using AidA-specific 710 
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antibodies. The production of AidA is dependent on the presence of cepI but not cciI. 711 
Addition of external AHL molecules (100 nM of C8-HSL for the cepI mutant, 100 nM 712 
C6-HSL for the cciI mutant and both signal molecules for the double mutant) restored 713 
AidA expression of the cepI mutant to the level of the wild type. 714 
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Table 1. Pathogenicity of various Bcc strains for G. mellonella and C. elegans. 715 
% Dead G. mellonella 
Strain 
24 h p.i. 48 h p.i. 
C. elegansc Reference 
B. cenocepacia H111 3 ± 5a 100 ± 0 3 (54) 
B. cenocepacia H111-aiiA 3 ± 6 7 ± 12 0 (75) 
B. cenocepacia K56-2 67 ± 29 100 ± 0 3 (45) 
B. cenocepacia J2315 0 ± 0 78 ± 29 1 (45) 
B. cepacia R18194 71 ± 30 100 ± 0 2 (65) 
B. stabilis R6281 6 ± 10 56± 11 0 (25) 
B. dolosa LMG21820 12 ± 14 9 ± 16 0 (72) 
B. ambifaria LMG17828 13 ± 6 100 ± 0 3 (13) 
B. ambifaria LMG17828-aiiA 3 ± 6 10 ± 10 0 (75) 
B. multivorans LMG18822 0 ± 0 42 ± 7 0 (25) 
B. vietnamiensis LMG10929 14 ± 13 100 ± 0 0 (13) 
B. vietnamiensis LMG10929-aiiA 0 ± 0 3 ± 5 0 (75) 
B. pyrrocinia LMG21822 59 ± 12 100 ± 0 3 (13) 
B. anthina LMG20983 9 ± 16 18 ± 16 3 (13) 
E. coli OP50b 0 ± 0 3 ± 0 0 (43) 
 716 
a
 Values are means of percent dead larvae ± standard deviation. 717 
b
 E. coli OP50 was included as a control. 718 
c
 Pathogenicity score according to (8) and (75).  719 
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Table 2. Virulence of QS mutants of B. cenocepacia H111 and K56-2 in different 720 
infection models. 721 
Strain Function loss 
% of wild type 
virulence in C. 
elegansa 
% of wild type 
virulence in G. 
mellonellab 
% Alfalfa 
seedlings with 
symptomsc 
Animal 
infection 
studies 
(mouse/rat)d 
Reference(s) 
H111-I  cepI 23 ± 5* 0 ± 0* 17 ± 26* NS (25) 
H111-R  cepR 24 ± 12* 100 ± 0 23 ± 32* ND (28) 
H111-R 
(pBAH27)  
cepR (cepR+) 100 ± 9 100 ± 0 ND ND (28) 
K56-I2  cepI 7 ± 4* 100 ± 0 100 ± 0 A, B (40, 63) 
K56-2cciI  cciI 86 ± 12 100 ± 0 100 ± 0 A (3) 
K56-2cepIcciI   cepI cciI 0 ± 0* 100 ± 0 100 ± 0 ND (48) 
 722 
a
 As the killing rates of H111 and K56-2 in C. elegans differed greatly, the percentage of dead nematodes 723 
was determined after 48 h for H111and after 72 h for K56-2 strains, respectively. Virulence of the wild type 724 
strains was set to 100%. 725 
b
 Percentage of dead larvae was determined 48 h postinfection.  Virulence of the wild type strains was set to 726 
100%. 727 
c
 Inoculated alfalfa seedlings were inspected for disease symptoms characterized by yellow or brown leaves 728 
and necrosis of the roots 5 days post infection. Virulence of the wild type strains was 100%. Assays were 729 
performed at least three times with at least 10 seedlings per assay and values shown are the mean ±SD of 730 
the three assays. 731 
dAnimal data for K56-2 strains are from (61) and (2). The following pathogenicity index is used: A, Lungs 732 
infected with mutants had 25-50% less inflammation than K56-2 determined by quantitative histopathology 733 
analysis of hematoxylin and eosin stained sections of lungs from chronic infections using the rat agar bead 734 
model. Lung sections were scanned using an Epson 1650 scanner, and areas of inflammation were digitized 735 
with SCION IMAGE software (http://www.scioncorp.com) and reported as the percentage of lung 736 
inflammation. Mean ± SD of groups of 4-5 animals significantly different (p<0.01 by ANOVA). B. 737 
Significantly less virulent in intranasally infected Cftr(-/-) mice than K56-2 determined by gross pathology 738 
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scoring for inflammation, 2-3 log less bacteria recovered from lungs (p< 0.02) and lack of dissemination 739 
into the spleen of infected animals (61). ND, not determined; NS, no significant difference to the wild type.  740 
*Significantly different than wild type: P<0.05 ANOVA (alfalfa) or t-test (C. elegans and G. mellonella).  741 
 742 
 743 
 744 
Table 3. Virulence of various B. cenocepacia H111 and K56-2 mutants in different 745 
infection models. 746 
 Strain  Mutation % of wild type 
virulence in  
C. elegans
a
 
% of wild type 
virulence in  
G. mellonella
b
 
% Alfalfa 
seedlings with 
symptoms
c
 
Animal 
infection 
studies 
(mouse/rat)d 
Reference  
H111-A   aidA  40 ± 19*  94 ± 10  69 ± 53  NS
g
 
(25) 
H111gspE   gspE  100 ± 6  83 ± 29  66 ± 32   ND  (33) 
K56-2orbA::tp   orbA  66 ± 18*  3 ± 6*  98 ± 3
e
 
A, B (58) 
K56-2-I117   pvdA  0 ± 0*  41 ± 28*  85 ± 13*  A, B (59) 
K56-2-9   zmpA  100 ± 11  100 ± 0  100 ± 0
e
 
A, B (14) 
K56-2zmpB::tp   zmpB  100 ± 17  100 ± 0  100 ± 0  B (32) 
K56-2 RSF13   htrA  100 ± 13  100 ± 0  100 ± 0  B (20) 
K56-2bscN::cat   bscN  60 ± 24* 100 ± 0 87 ±15 C (65)f 
K56-2 Sal1   hldA  30 ± 37* 52 ± 22* 100 ± 0 A (39) 
K56-2opcI   opcI  97 ± 8 100 ± 0 100 ± 0 B (2) 
K56-2 S76   lysR  100 ± 0 100 ± 0 0 ± 0e * B (3) 
K56-20225   lysR  97 ± 5 100 ± 0 0 ± 0e * ND (3) 
K56-2RSF12   Regulator  99 ± 21 100 ± 0 96 ± 6 A (20) 
 747 
a
 As the killing rates of H111 and K56-2 in C. elegans differed greatly, the percentage of dead nematodes 748 
was determined after 48 h for H111and after 72 h for K56-2 strains, respectively. Virulence of the wild type 749 
strains was set to 100%. 750 
b
 Percentage of dead larvae was determined 48 h postinfection. Virulence of the wild type strains was set to 751 
100%. 752 
c
 Inoculated alfalfa seedlings were inspected for disease symptoms characterized by yellow or brown leaves 753 
and necrosis of the roots 5 days post infection. Virulence of the wild type strains was 100%. Assays were 754 
performed at least three times with at least 10 seedlings per assay and values shown are the mean ±SD of 755 
the three assays 756 
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d
 Data for K56-2 strains are taken from the literature. The following pathogenicity index is used: A, Mutant 757 
has significantly reduced ability to persist by at least 3 logs in lungs of rats infected using the agar bead 758 
model (p<0.05) determined between 7-28 days p.i; B, Lungs infected with mutants had at least 50% less 759 
inflammation than K56-2 determined as described in the legend to Table 2; Mean ± SD of groups of 4-5 760 
animals significantly different (p<0.05, ANOVA). C, From Tomich et al (65) comparing strain 761 
J2315bscN::cat to J2315using the mouse agar bead model. Mutant had significantly reduced ability to 762 
persist by 3 logs in lungs of infected mice 72 hr p.i. (p<0.02, Student’s unpaired t-test). Qualitative 763 
differences in lung histopathology also reported between mutant and WT.  ND, not determined; NS, no 764 
significant difference to the wild type.  765 
e
 Data taken from (5) and (4). 766 
f
 Tomich et al. (67) tested strain J2315bscN::cat. 767 
g
 NS not significantly different from wild type when animals infected with either 104 or 105 cfu bacteria 768 
encased in agar beads. 769 
*Significantly different than wild type: P<0.05 ANOVA (alfalfa) or t-test (C. elegans and G. mellonella).  770 
 771 
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